|Bid||100.34 x 800|
|Ask||101.75 x 800|
|Day's Range||100.88 - 102.43|
|52 Week Range||63.22 - 107.24|
|Beta (5Y Monthly)||0.27|
|PE Ratio (TTM)||34.46|
|Forward Dividend & Yield||1.47 (1.45%)|
|Ex-Dividend Date||Aug 16, 2021|
|1y Target Est||106.36|
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 20 September 2021 – On 4 August 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 18 billion to be executed during a 12-month period
These two companies have outperformed the market in the past year, and they are likely to continue doing so.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.